Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4

This prespecified analysis of the EAST-AFNET 4 trial used baseline left atrial diameter, PR interval, and NT-proBNP to quantify atrial cardiomyopathy in patients with recently diagnosed AF. Outcome rates were compared between atrial cardiomyopathy categories, and interactions between atrial cardiomyopathy and early rhythm-control were determined. Most patients had atrial cardiomyopathy (84% with enlarged left atria). Patients with advanced atrial cardiomyopathy had higher rates of primary outcome during follow-up. Early rhythm control was effective with and without atrial cardiomyopathy (Pinteraction = 0.160).

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2025-10-01
DOI
https://doi.org/10.1093/europace/euaf256
Citations
5
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
6.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4

Lars Eckardt, A. John Camm, Andreas Goette, Günter Breithardt et al.
5 citations
EP Europace
Atrial Fibrillation Management and Outcomes
6.94
article

Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4

Lars Eckardt, A. John Camm, Andreas Goette, Günter Breithardt, Katrin Borof, Ulrich Schotten, Paulus Kirchhof, Larissa Fabritz, Andreas Metzner, Antonia Zapf, Stephan Willems, Renate B. Schnabel, Harry J.G.M. Crijns, Marc D. Lemoine
article en
5 citations

Abstract

This prespecified analysis of the EAST-AFNET 4 trial used baseline left atrial diameter, PR interval, and NT-proBNP to quantify atrial cardiomyopathy in patients with recently diagnosed AF. Outcome rates were compared between atrial cardiomyopathy categories, and interactions between atrial cardiomyopathy and early rhythm-control were determined. Most patients had atrial cardiomyopathy (84% with enlarged left atria). Patients with advanced atrial cardiomyopathy had higher rates of primary outcome during follow-up. Early rhythm control was effective with and without atrial cardiomyopathy (Pinteraction = 0.160).

EP EuropaceVol. 27(10)
Universität Hamburg (DE), St George's, University of London (GB), Maastricht University Medical Centre (NL), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), Atrial Fibrillation NETwork (DE), Asklepios Klinik St. Georg (DE), St. Vincenz-Krankenhaus Limburg (DE), Otto-von-Guericke-Universität Magdeburg (DE)
Sanofi, Deutsches Zentrum für Herz-Kreislaufforschung, Kompetenznetz Vorhofflimmern, British Heart Foundation, European Commission, Fondation Leducq, Deutsche Herzstiftung
Openalex Percentile: Top 3%
Atrial Fibrillation Management and Outcomes
6.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.